Assesses drug assets and the companies behind them, critiques evaluation rubrics and judges the quality of investment theses over a short pilot. Suits senior biotech or healthcare investment analysts with specialist-fund experience.
About the role
This role is for one of our clients
Compensation: $120 - $200 per hour
We are partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales.
Requirements
Responsibilities
- Create and critique rubrics that analyze commercial drugs and drug-development programs
- Provide overall company and asset assessment — mechanism, clinical data, competitive position, and value drivers
- Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions
- Apply your assessment across the pilot's set of companies (~5–10)
- Apply your assessment across the pilot's set of companies (~5–10)
- US-based biotech / healthcare investment analyst with a specialist-fund background
- Familiarity with biotech/pharma development programs
- Able to assess a drug asset and the company behind it end-to-end
- 5+ years evaluating biotech/pharma companies or assets
- 5+ years evaluating biotech/pharma companies or assets
- Duration: Approximately 10–20 hours over a 1–2 week pilot
- Remote — US-based
- Remote — US-based
- Help improve expert AI evaluation of drugs and drug-development programs
- Recurring engagement for strong contributors
- Recurring engagement for strong contributors
Official source: apply.workable.com. Details can change; the platform's page is the final word. Something wrong with this listing? Tell us.
More finance and accounting jobs All Weekday roles What finance professionals earn AI training jobs for finance and accounting professionals in the US How much does Weekday pay? Jobs in US
